Episode

Discussing RA: Malignancy risk in patients with RA and the evolution of JAKi prescriptions

Podcast
The IMID Forum
Published
Mar 26, 2026
Duration seconds
602
Processing state
not_requested
Canonical source
https://soundcloud.com/imidforum/discussing-ra-malignancy-risk
Audio
https://feeds.soundcloud.com/stream/2290385534-imidforum-discussing-ra-malignancy-risk.mp3
JSON
/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-ra-malignancy-risk-in-patients-with-ra-and-the-evolution-of-jaki-prescriptions
Markdown
/podcast/the-imid-forum-981476/discussing-ra-malignancy-risk-in-patients-with-ra-and-the-evolution-of-jaki-prescriptions.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-ra-malignancy-risk-in-patients-with-ra-and-the-evolution-of-jaki-prescriptions/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-imid-forum-981476/discussing-ra-malignancy-risk-in-patients-with-ra-and-the-evolution-of-jaki-prescriptions.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review a paper a paper on the malignancy risk in patients with RA initiating b/tsDMARDS, and the evolution of JAKi prescriptions since 2015 in an international collaboration of rheumatoid arthritis registers.